Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion

The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air–liquid interface (ALI) and exposed to CS. Expre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ERJ Open Res
Main Authors: Kim, Michael D., Baumlin, Nathalie, Dennis, John S., Yoshida, Makoto, Kis, Adrian, Aguiar, Carolina, Schmid, Andreas, Mendes, Eliana, Salathe, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836504/
https://ncbi.nlm.nih.gov/pubmed/33532463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00394-2020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados